Dianthus Therapeutics, Inc. · NASDAQ:DNTH
BlackRock, Inc.'s stake in Dianthus Therapeutics, Inc. fell to 5.00% (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 24, 2025
BlackRock, Inc.'s stake in Dianthus Therapeutics, Inc. fell to 5.00%, 1,600,153 shares, as a passive investor on Mar 31, 2025. Filed Apr 24, 2025 (Schedule 13G/A).
- Stake
- 5.00%
- Shares
- 1,600,153
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.00% | 1,600,153 |
Source
Related
- Dianthus Therapeutics, Inc.
- BlackRock, Inc.
- Dianthus Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026